Hyderabad, March 14,2014: According to the US Food and Drug Administration, the Hyderabad-based company was recalling 58,656 bottles of the drug due to a microbial contamination.
The recall has been classified as ‘Class II’, which, as per FDA norms, is not a serious problem, with only a remote chance of severe adverse consequences from contamination in the product.
A Dr Reddy’s spokesperson said that it was a voluntary recall and that there was no financial implication.
On the Bombay Stock Exchange, the Dr Reddy’s scrip ended Thursday at Rs. 2,734, up 1.63 per cent.